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In inﬂammation, bacterial products and proinﬂammatory cytokines induce the formation of large amounts of nitric oxide (NO)
by inducible nitric oxide synthase (iNOS), and compounds that inhibit NO production have anti-inﬂammatory eﬀects. In the
present study, we systematically investigated the eﬀects of 36 naturally occurring ﬂavonoids and related compounds on NO pro-
duction in macrophages exposed to an inﬂammatory stimulus (lipopolysaccharide, LPS), and evaluated the mechanisms of action
of the eﬀective compounds. Flavone, theisoﬂavones daidzein and genistein, theﬂavonols isorhamnetin,kaempferol andquercetin,
the ﬂavanone naringenin, and the anthocyanin pelargonidin inhibited iNOS protein and mRNA expression and also NO produc-
tion in a dose-dependent manner. All eight active compounds inhibited the activation of nuclear factor-κB( N F - κB), which is a
signiﬁcant transcription factor for iNOS. Genistein, kaempferol, quercetin, and daidzein also inhibited the activation of the sig-
nal transducer and activator of transcription 1 (STAT-1), another important transcription factor for iNOS. The present study
characterises the eﬀects and mechanisms of naturally occurring phenolic compounds on iNOS expression and NO production in
activated macrophages. The results partially explain the pharmacological eﬃcacy of ﬂavonoids as anti-inﬂammatory compounds.
Copyright © 2007 Mari H¨ am¨ al¨ ainen et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Nitric oxide (NO) is produced from L-arginine by three
nitric oxide synthase (NOS) enzymes; endothelial NOS
(eNOS),neuronalNOS(nNOS),andinducibleNOS(iNOS).
Low physiological levels of NO are produced by constitu-
tively expressed eNOS and nNOS, whereas iNOS is responsi-
bleforprolongedproductionoflargeramountsofNO.iNOS
is induced by bacterial products and inﬂammatory cytokines
in macrophages and some other cells [1–3]. NO production
is increased in inﬂammation and has proinﬂammatory and
regulatory eﬀects [4, 5]. In addition, peroxynitrite formation
in a reaction of NO and superoxide may lead to increased cy-
totoxicity. The experimental data support the idea that com-
pounds inhibiting expression or activity of iNOS are poten-
tial anti-inﬂammatory agents [6–9].
Flavonoids are naturally occurring polyphenolic com-
pounds containing two benzene rings linked together with
a heterocyclic pyran or pyrone ring. Flavonoids are nor-
mal constituents of the human diet and are known for a
variety of biological activities. Some of these act as en-
zyme inhibitors and antioxidants, and have been reported to
have anti-inﬂammatory properties. However, the molecular
mechanisms explaining how ﬂavonoids suppress the inﬂam-
matory response are not known in detail [10, 11]. There are
studies showing that certain ﬂavonoids down-regulate NO2 Mediators of Inﬂammation
productioninresponsetoinﬂammatorystimuli[12–14],but
no more precise mechanisms of action are known.
In the present study, we investigated the eﬀects of 36 nat-
urally occurring compounds representing diﬀerent groups
of ﬂavonoids and related compounds on iNOS expression
a n dN Op r o d u c t i o ni na c t i v a t e dm a c r o p h a g e ss y s t e m a t i c a l l y ,
and evaluated the mechanisms of action of the eﬀectivecom-
pounds.
2. MATERIALS AND METHODS
2.1. Materials
Luteolin, luteolin-7-glucoside, vitexin, daidzein, genistein,
genistin, rhamnetin, isorhamnetin, kaempferol, myricetin,
taxifolin, naringin, ferulic acid, pelargonidin, procyanidin
B1, and procyanidin B2 were obtained from Extrasyn-
these (Lyon, France). Acacetin, cyanidin, ﬂavone, morin,
and quercitrin were obtained from Carl Roth GmbH (Karl-
sruhe, Germany). Quercetin, rutin, and benzoic acid were
obtained from Merck (Darmstadt, Germany). Naringenin,
+catechin, −epicatechin,ellagicacid,gallicacid,andsyringic
acid were obtained from Sigma (St. Louis, MO, USA). Api-
genin, chlorogenic acid, dodecyl gallate, methyl gallate, octyl
gallate, and sinapic acid were obtained from Fluka (Buchs
SG, Switzerland).
Dulbecco’s modiﬁed eagle medium and its supplements
were obtained from Gibco BRL (Paisley, UK). All other
reagentswereobtainedfromSigma(St.Louis,MO,USA)un-
less otherwise stated.
2.2. Cellculture
Murine J774 macrophages were obtained from American
Type Culture Collection (Rockville, MD, U.S.A). Cells were
cultured at 37◦C (in 5% carbon dioxide) in Dulbecco’s
modiﬁed eagle’s medium (DMEM) with glutamax-I con-
taining 10% heat-inactivated foetal bovine serum, penicillin
(100units/ml), streptomycin (100μg/ml), and amphotericin
B(250ng/ml).Cellswereharvestedwithtrypsin-EDTA.Cells
were seeded in 96-well plates for XTT-test, in 24-well plates
for nitrite measurements, in 6-well plates for iNOS Western
blot and RNA extraction, and in 10-cm dishes for p65 and
STAT-1α Western blot. Conﬂuent cells were exposed to fresh
culture medium containing the compounds of interest and
cultured for the times indicated.
2.3. XTT-test
Cell viability was tested using cell proliferation kit II
that measures the cells’ ability to metabolize XTT to for-
mazan by mitochondrial dehydrogenase activity, a func-
tion that only occurs in viable cells (Roche Diagnostics
GmbH, Mannhein, Germany). Cells were incubated with the
tested compounds and LPS for 20 hours before addition
of sodium 3’-[1-(phenylaminocarbonyl)-3,4-tetrazolium]-
bis (4-methoxy-6-nitro) benzene sulphonic acid hydrate
(XTT) (ﬁnal concentration 0.3mg/ml) and N-methyl diben-
zopyrazine methyl sulphate (8.2μM). Cells were incubated
for another 4 hours and the amount of formazan accumulat-
ing in growth medium was assessed spectrophotometrically.
Triton-X treated cells were used as a positive control. Condi-
tions were considered nontoxic if the cells’ ability to metab-
olize XTT to formazan was more than 80% of that of cells
exposed to LPS only.
2.4. Nitritedeterminations
Measurement of nitrite accumulation into the culture
medium was used to determine NO production. At the in-
dicated time points, the culture medium was collected and
nitrite was measured by the Griess reaction [15]. A NOS in-
hibitor L-NIO (1mM) and a highly selective iNOS inhibitor
1400W (1mM) were added at the beginning of the incuba-
tion to cells that were stimulated with LPS (100ng/ml) to en-
sure that the measured nitrite was due to NO produced by
the iNOS pathway in the cell culture.
2.5. PreparationofcelllysatesforiNOSWesternblot
Afterthedesiredtimeofincubationcelllysateswereprepared
as described earlier [16]. The Coomassie blue method was
used to measure the protein content of the samples [17].
2.6. Preparationofnuclearextractsforp65and
STAT-1αWesternblot
Cells were seeded on 10-cm dishes and were grown to con-
ﬂuence. Cells were incubated with the compounds of inter-
est for 30 minutes (p65) or for 6 hours (STAT-1α). After in-
cubation, samples were prepared as described earlier [18].
The Coomassie blue method was used to measure the pro-
tein content of the samples [17].
2.7. WesternblotanalysisofiNOS,p65,andSTAT-1α
proteins
Protein samples (20μg) were separated by SDS-PAGE on 8%
polyacrylamide gel and transferred to nitrocellulose mem-
brane. Bound antibody (rabbit polyclonal antibodies for
iNOS, STAT-1α (Santa Cruz Biotechnology, Santa Cruz, CA,
USA), or for p65 subunit of NF-κB (Cell Signaling Danvers,
MA, USA)) was detected using goat anti-rabbit polyclonal
antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA),
and visualised by SuperSignal chemiluminescent substrate
(Pierce, Cheshire, UK) and FluorChem 8800 imaging system
(Alpha Innotech Corporation, San Leandro, CA). The quan-
titation of the chemiluminescent signal was carried out using
FluorChem software version 3.1.
2.8. RNAextractionandreal-timeRT-PCRofiNOSand
GAPDHmRNAs
J774 cells stimulated with the compounds of interest were
trypsinised after the desired time of incubation. Cell ho-
mogenization, RNA extraction, reverse transcription, and
quantitative PCR were performed as described earlier [16].
The primer and probe sequences and concentrations wereMari H¨ am¨ al¨ ainen et al. 3
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Figure 1: Basic chemical structures of the phenolic compounds used in the present study.
optimized according to the manufacturer’s instructions in
TaqMan Universal PCR Master Mix Protocol part num-
ber 4304449 revision C and were as follows: 5’-CCTG-
GTACGGGCATTGCT-3’, 5’-GCTCATGCGGCCTCCTT-
3’, (forward and reverse mouse iNOS primers, resp., both
300nM), 5’-CAGCAGCGGCTCCATGACTCCC-3’ (mouse
iNOS probe containing 6-FAM as 5’-reporter dye and
TAMRA as 3’-quencher, 150nM), 5’-GCATGGCCTTC-
CGTGTTC-3’, 5’-GATGTCATCATACTTGGCAGGTTT-3’
(forward and reverse mouse glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH) primers, resp., both 300nM), 5’-T-
CGTGGATCTGACGTGCCGCC-3’ (mouse GAPDH probe
containing 6-FAM as 5’-reporter dye and TAMRA as 3’-
quencher, 150nM). Results of iNOS mRNA levels were nor-
malized against GAPDH mRNA in each sample.
2.9. Statistics
Results are expressed as mean ± standard error of mean
(SEM). The statistical signiﬁcance of the detected diﬀerences
was calculated by analysis of variance followed by Dunnett
multiple comparison’s test. Diﬀerences were considered sig-
niﬁcant when P<. 05.
3. RESULTS
The tested compounds (n = 36) represented eight groups
of ﬂavonoids and related compounds: ﬂavones, isoﬂavones,
ﬂavonols, ﬂavanones, ﬂavan-3-ols, anthocyanins, hydrox-
ybenzoic acid (HBA) group, and hydroxycinnamic acid
(HCA) group. The tested compounds are listed and their
structures are shown in Figure 1 and Table 1.Possible cyto-
toxic eﬀects were tested by XTT-test. Compounds that were
toxic at 100μM (see Table 2) were excluded from further
studies.
3.1. EffectsofﬂavonoidsonLPS-inducedNO
productioninJ774cells
Untreated J774 macrophages did not produce detectable
amounts of NO during 24-hour incubation, but LPS
(100ng/ml) enhanced NO production signiﬁcantly. In the
ﬁrst experiments, ﬂavonoids were used at 10μM and 100μM
concentrations. The compounds inhibiting NO produc-
tion by more than 50% at 100μM concentration com-
pared to LPS-treated control were ﬂavone, daidzein, genis-
tein, isorhamnetin, kaempferol, quercetin, naringenin, and
pelargonidin (see Table 2). NOS inhibitor L-NIO (1mM)
and a selective iNOS inhibitor 1400W (1mM) were used
as control compounds, and they inhibited LPS-induced NO
production by more than 90%.
If the compound inhibited NO production by more
than 50% at 100μM concentration, a dose-response eﬀect
was studied. All eight active compounds (ﬂavone, daidzein,
genistein, isorhamnetin, kaempferol, quercetin, naringenin,4 Mediators of Inﬂammation
Table 1: Chemical structures of the phenolic compounds used in the present study.
Class Derivatives
Substituents
1∗
3 5 7 3’ 4’ 5’
Flavones
Acacetin H OH OH H OCH3 H
Apigenin H OH OH H OH H
F l a v o n e HHHHHH
Luteolin H OH OH OH OH H
Lut-7-glucoside H OH OGlc OH OH H
Vitexin H OH OH H OH H 8G l c
Isoﬂavones
Daidzein H H OH H OH H
Genistein H OH OH H OH H
Genistin H OH OGlc H OH H
Flavonols
Isorhamnetin OH OH OH OCH3 OH H
Kaempferol OH OH OH H OH H
M o r i n O HO HO HH O HH 2’ OH
M y r i c e t i n O HO HO HO HO HO H
Q u e r c e t i n O HO HO HO HO HH
Quercitrin ORha OH OH OH OH H
R h a m n e t i n O HO HO C H 3 OH OH H
Rutin ORu OH OH OH OH H
Flavanones
Naringenin H OH OH H OH H
Naringin H OH ONeo H OH H
T a x i f o l i n O HO HO HO HO HH
Flavan-3-ols
+Catechin OH OH OH OH OH H
−Epicatechin OH OH OH OH OH H
Procyanidin B1 Dimer of epicatechin and catechin linked via their carbons 4 and 8, respectively.
Procyanidin B2 Dimer of two epicatechin molecules linked via carbons 4 and 8.
Anthocyanins Cyanidin OH OH OH OH OH H
Pelargonidin OH OH OH H OH H
HBA
Benzoic acid H H 4H
Dodecyl gallate COO(CH2)11CH3 OH OH
Ellagic acid see below
Gallic acid OH OH
Methyl gallate COOCH3 OH OH
Octyl gallate COOCH2(CH2)6CH3 OH OH
Syringic acid OCH3 OCH3
HCA
Chlorogenic acid see below
Ferulic acid OCH3
Sinapic acid OCH3 OCH3
∗if other than in basic structure
Glc=glycoside, Rha=rhamnoside, Ru=rutinoside, Neo=neohesperidoside
OH group is in front of plane of paper, OH group is behind plane of paper
O
O
O
O
OH OH
OH
OH
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O
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OH OH
OH
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Table 2: Eﬀects of phenolic compounds on cell viability and on LPS-induced (100ng/ml) NO production in J774 macrophages. No de-
tectable NO production was found in untreated cells. Mean ± standard error of mean (SEM).
Class Toxicity(a) NO production (inhibition%)
Derivatives [100μM] [10μM] [100μM]
LPS 100ng/ml 00
Flavones
Acacetin +
Apigenin +
Flavone − 20.4 ±1.79 2 .8 ±0.6
Luteolin +
Luteolin-7-glucoside − 3.1 ±1.73 8 .6 ±1.1
Vitexin −− 1.9 ±0.86 .2 ±0.7
Isoﬂavones
Daidzein − 11.3 ±6.37 0 .3 ±3.1
Genistein − 11.6 ±2.49 7 .4 ±0.2
Genistin − 9.7 ±2.11 3 .3 ±2.0
Flavonols
Isorhamnetin − 3.5 ±0.96 5 .1 ±1.6
Kaempferol − 8.4 ±2.29 9 .6 ±0.2
Morin − 4.8 ±1.34 0 .8 ±2.4
Myricetin −− 0.6 ±2.63 2 .3 ±2.8
Quercetin −− 1.5 ±5.18 9 .7 ±0.3
Quercitrin − 5.1 ±0.81 9 .1 ±0.8
Rhamnetin +
Rutin −− 2.2 ±2.08 .7 ±1.0
Flavanones
Naringenin − 14.7 ±1.35 9 .6 ±3.3
Naringin − 1.9 ±2.53 .9 ±2.1
Taxifolin − 3.1 ±1.82 3 .9 ±1.8
Flavan-3-ols
+ Catechin +
− Epicatechin −− 0.6 ±1.8 −0.1 ±1.0
Procyanidin B1 −− 8.4 ±1.4 −2.2 ±1.9
Procyanidin B2 −− 0.6 ±2.50 .8 ±1.7
Anthocyanins
Cyanidin −− 4.9 ±3.85 .3 ±1.8
Pelargonidin − 4.5 ±1.15 9 ±0.8
HBA (b)
Benzoic acid − 0.7 ±2.0 −4.0 ±1.5
Dodecyl gallate +
Ellagic acid −− 15.1 ±3.03 8 .2 ±1.9
Gallic acid +
Methyl gallate − 11.2 ±0.93 0 .5 ±1.0
Octyl gallate +
Syringic acid − 6.7 ±1.55 .1 ±1.6
HCA (c)
Chlorogenic acid −− 4.8 ±3.5 −0.9 ±2.0
Ferulic acid − 6.6 ±1.19 .0 ±1.5
Sinapic acid − 8.9 ±1.95 .2 ±1.3
n = 6 n = 6 n = 6
(a)Cytotoxicity was tested by XTT-test and compounds that showed cytotoxicity at 100μM concentrations were excluded from further study. (b)HBA =
hydroxybenzoic acid, (c)HCA = hydroxycinnamic acid, n = number of replicates.6 Mediators of Inﬂammation
and pelargonidin) inhibited NO production in a dose-
dependent manner in the following order: quercetin (IC50∼
25μM) ∼ kaempferol (IC50∼ 25μM) > genistein (IC50∼
30μM) ∼isorhamnetin (IC50∼ 30μM) > ﬂavone (IC50∼
40μM) > daidzein (IC50∼ 70μM) > naringenin (IC50∼
80μM) > pelargonidin (IC50∼ 90μM) (see Figure 2).
3.2. EffectsofﬂavonoidsonLPS-inducediNOS
proteinexpression
The eﬀects of those eight ﬂavonoids inhibiting NO produc-
tion by more than 50% at 100μM concentrations were tested
on iNOS protein expression by Western blot analysis. Un-
stimulated cells did not express detectable amounts of iNOS
protein and LPS enhanced iNOS protein expression consid-
erably. All eight active compounds (ﬂavone, daidzein, genis-
tein, isorhamnetin, kaempferol, quercetin, naringenin, and
pelargonidin) inhibited LPS-induced iNOS protein expres-
sion (see Figure 3).
3.3. EffectsofﬂavonoidsonLPS-inducediNOS
mRNAlevels
iNOS mRNA was measured by quantitative real-time RT-
PCR. Cells were incubated with LPS (100ng/ml) or with
LPS and the tested ﬂavonoid (ﬂavone, daidzein, genis-
tein, isorhamnetin, kaempferol, quercetin, naringenin, or
pelargonidin (100μM)) for 6 hours. This incubation time
was chosen according to the time curve of iNOS mRNA,
where the maximal iNOS mRNA levels were between 6 and
8 hours after addition of LPS. Untreated cells expressed very
l o wl e v e l so fi N O Sm R N Aa n dL P Se n h a n c e di N O Sm R N A
expression considerably. All eight tested ﬂavonoids signiﬁ-
c a n t l yl o w e r e di N O Sm R N Al e v e l sw h e nm e a s u r e da f t e r6 -
hour incubation in the following order of potency: quercetin
> kaempferol > genistein > isorhamnetin > ﬂavone > narin-
genin > daidzein ∼pelargonidin (see Figure 4).
3.4. EffectsofﬂavonoidsonLPS-inducedactivationof
transcriptionfactorsNF-κBandSTAT-1
NF-κB and STAT-1 are important transcription factors for
iNOS [19, 20]. Therefore we measured the eﬀects of the eight
eﬀective ﬂavonoids on NF-κB and STAT-1 activations by
measuring the nuclear translocation of the factors by West-
ern blot.
In unstimulated cells, low basal activity of NF-κBw a sd e -
tected and was signiﬁcantly enhanced after LPS challenge.
The maximal activation was found 30 minutes after LPS ad-
dition, and that incubation time was used in the subsequent
studies. Quercetin, naringenin and pelargonidin inhibited
the LPS-induced activation of NF-κB by more than 80%.
Flavone, genistein, isorhamnetin, kaempferol, and daidzein
had a moderate (57%–72% inhibition) inhibitory eﬀect (see
Figure 5).
Nuclear STAT-1 levels were signiﬁcantly enhanced after
LPS challenge. The maximal eﬀect was found 6 hours after
LPS addition, and that time point was chosen for subse-
quentstudies.TheLPS-inducedactivityofSTAT-1wasnearly
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Figure 2: (a) Eﬀects of increasing concentrations of ﬂavone,
daidzein, and genistein on LPS (100ng/ml)-induced NO produc-
tioninJ774cellsduringa24-hourincubationtime.(b)Eﬀectsofin-
creasingconcentrationsofquercetin,isorhamnetin,andkaempferol
on LPS (100ng/ml)-induced NO production in J774 cells during a
24-hour incubation time. (c) Eﬀects of increasing concentrations of
naringenin and pelargonidin on LPS (100ng/ml)-induced NO pro-
duction in J774 cells during a 24-hour incubation time. NO pro-
duction was determined by measuring nitrite accumulation in the
culture medium by Griess reaction. Mean + SEM, n = 6.Mari H¨ am¨ al¨ ainen et al. 7
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Figure 3: (a) Eﬀects of ﬂavone, daidzein, and genistein on LPS
(100ng/ml)-induced iNOS protein expression in J774 cells dur-
ing a 24-hour incubation time. (b) Eﬀects of quercetin, isorham-
netin, and kaempferol on LPS (100ng/ml)-induced iNOS protein
expression in J774 cells during a 24-hour incubation time. (c) Ef-
fects of naringenin and pelargonidin on LPS (100ng/ml)-induced
iNOS protein expression in J774 cells during a 24-hour incubation
time. iNOS protein expression was detected by Western blot. Mean
+S E M ,n = 3, ∗∗P<. 01.
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Figure 4: Eﬀects of ﬂavonoids on iNOS mRNA expression. Cells
were treated with LPS (100ng/ml) or with LPS and the tested com-
pound (100μM) and RNA was extracted after 6 hours. iNOS and
GAPDH mRNA were measured by real-time RT-PCR and iNOS
mRNA levels were normalised against GAPDH. Mean + SEM, n =
3, ∗∗P<. 01.
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Figure 5: Eﬀects of ﬂavonoids on LPS-induced NF-κB activation
determined as nuclear translocation of NF-κB. J774 cells were in-
cubated for 30 minutes with LPS (100ng/ml) or with LPS and the
ﬂavonoid (100μM), and nuclear proteins were extracted. Western
blot was used to detect the p65 subunits of NF-κB in the nuclear
extracts. p65 levels in LPS-treated cells were set at 100% and the
other values were related to that. The dotted line represents the nu-
clear p65 levels in untreated control cells. Mean + SEM, n = 4 − 6,
∗∗P<. 01 as compared to LPS-induced level.
totally (91% inhibition) inhibited by quercetin. Daidzein,
genistein, and kaempferol had a moderate (32%–41% in-
hibition) inhibitory eﬀect whereas ﬂavone, isorhamnetin,
naringenin, and pelargonidin showed no inhibitory eﬀect on
the activation of STAT-1 (see Figure 6).8 Mediators of Inﬂammation
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Figure 6: (a)–(c) Eﬀects of ﬂavonoids on LPS-induced STAT-1 ac-
tivation determined as nuclear translocation of STAT-1α. J774 cells
were incubated for 6 hours with LPS (100ng/ml) or with LPS and
the ﬂavonoid (100μM), and nuclear proteins were extracted. West-
e r nb l o tw a su s e dt od e t e c tS T A T - 1 α in the nuclear extracts. STAT-
1α levels in LPS-treated cells were set at 100% and the other values
were related to that. The dotted line represents the nuclear STAT-1α
levels in untreated control cells. Mean + SEM, n = 3, ∗∗P<. 01,
∗P<. 05 as compared to LPS-induced level.
4. DISCUSSION
Flavonoidsarenonessentialdietaryfactors,andhumanscon-
sume about 1-2g of ﬂavonoids daily. Flavonoids are abun-
dantly present in fruits, vegetables, seeds, nuts, tea, and
red wine, and the ﬂavonoid mostly consumed is quercetin.
Flavonoids are believed to act as health-promoting sub-
stances, and some of them have antioxidant and anti-
inﬂammatory properties [10, 11]. Anti-inﬂammatory eﬀects
have also been found in vivo. For instance, genistein was re-
ported to inhibit LPS-induced septic response in rat [21]a n d
quercetin suppressed experimentally induced arthritis in rat
[22].
In the present study, we investigated the eﬀects of
ﬂavonoids and related compounds belonging to eight classes
(ﬂavones, isoﬂavones, ﬂavonols, ﬂavanones, ﬂavan-3-ols,
anthocyanins, HBA, and HCA) on iNOS expression and
NO production in activated macrophages. Eight eﬀec-
tive compounds were found. Four compounds (genistein,
kaempferol, quercetin, and daidzein) inhibited LPS-induced
STAT-1 and NF-κB activations, and iNOS expression. In ad-
dition, four compounds (ﬂavone, isorhamnetin, naringenin,
and pelargonidin) inhibited NF-κB activation and iNOS ex-
pression but had no eﬀect on STAT-1.
IsoﬂavonesdaidzeinandgenisteininhibitedLPS-induced
iNOS expression and NO production in a dose-dependent
manner, whereas genistin was less eﬀective. Daidzein and
genistein also inhibited activations of STAT-1 and NF-κB,
which are important transcription factors for iNOS [19, 20].
To our knowledge, their eﬀects on STAT-1 activation have
not been reported previously, whereas suppression of DNA-
binding of NF-κB by genistein has been reported [23]. Our
results conﬁrm earlier observations on the inhibitory eﬀects
of daidzein and genistein on iNOS expression and NO pro-
duction [13, 24–27], and provide a mechanism for the eﬀect
through suppression of STAT-1 and NF-κB activations.
In the ﬂavonol group, isorhamnetin, kaempferol, and
quercetin inhibited NO production and iNOS protein and
mRNA expression, quercetin and kaempferol being the most
potent of the phenolic compounds tested. Isorhamnetin,
kaempferol, and quercetin all inhibited NF-κB activation,
and quercetin and kaempferol also had an eﬀect on STAT-
1 activation. This is the ﬁrst study to show that isorham-
netin reduces iNOS expression, and that the eﬀect may well
be mediated by inhibition of NF-κB activation. Kaempferol
has previously been shown to inhibit iNOS expression and
NO production [13, 28]. Here we conﬁrm those ﬁndings
andshowthatkaempferolinhibitsSTAT-1andNF-κBacti va-
tions, which are implicated in their eﬀects on iNOS expres-
sion. Chen et al. [29] have reported that quercetin inhibits
IFNγ-induced STAT-1 activation in mouse BV-2 microglia.
In the present study we found that quercetin also suppressed
LPS-induced activation of STAT-1 in macrophages support-
ing the idea that its eﬀects on STAT-1 are stimulus and cell-
type independent. Quercetin inhibited LPS-induced STAT-1
activation along with its inhibitory eﬀect on iNOS expres-
sion and NF-κB activation. Inhibition of STAT-1 activation
by quercetin is likely involved in the mechanisms by which
it inhibits iNOS expression because JAK inhibitors AG-490Mari H¨ am¨ al¨ ainen et al. 9
and WHI-P154 have been shown to inhibit iNOS expres-
sion along with their suppressive actions on STAT-1 activa-
tion [18, 30].
Concurring with earlier results, we found ﬂavanone
naringenin to inhibit LPS-induced NO production while its
glycosylated counterpart naringin had no eﬀect[31]. Our re-
sults suggest that the inhibitory eﬀect of naringenin is likely
to be at transcriptional level through inhibition of the activa-
tion of NF-κB. Pelargonidin has been reported to inhibit NO
production in macrophages [26]. Here we extend the data by
showing that pelargonidin suppresses NO production by re-
ducing iNOS expression through inhibiting the activation of
transcription factor NF-κB.
Regarding the structural requirements of ﬂavonoids for
the inhibition of NO production, three main features could
be found:
(a) a C-2,3 double bond is a common feature in the six
most eﬀective compounds,
(b) a bulky group (e.g., glycoside, rhamnoside, ruti-
noside, or neohesperidoside) as a substituent lowered or
abolished the compound’s inhibitory eﬀect (e.g., quercetin
was highly eﬀective whereas its rhamnoside-substituted
derivative quercitrin was ineﬀective),
(c) 7 and 4’ OH-groups were found in all eﬀective com-
pounds but this alone did not diﬀerentiate active from inef-
fective compounds.
Related structure-activity relationships regarding PGE2
inhibition have been reported in rat peritoneal macrophages
[32].
Earlier studies have shown that some ﬂavonoids inhibit
NO production in response to inﬂammatory stimuli [13, 26,
28, 33, 34]. The present study extends the previous knowl-
edge by systematically comparing the eﬀects of a large se-
ries of compounds in standardized experimental conditions.
Moreover, we investigated the eﬀects of the eight eﬀective
compounds not only on NO production but also on iNOS
mRNA and protein expression, and on the activation of in-
ﬂammatory transcription factors NF-κB and STAT-1. Some
anti-inﬂammatory ﬂavonoids have been shown to inhibit ac-
tivation of NF-κB and the eﬀect has been linked to their an-
tioxidantproperties[29,35].Herewefoundthatalltheeﬀec-
tive compounds (ﬂavone, daidzein, genistein, isorhamnetin,
kaempferol, quercetin, naringenin, and pelargonidin) inhib-
ited LPS-induced NF-κB activation. In addition, genistein,
kaempferol, quercetin, and daidzein also inhibited STAT-1
activation. To our knowledge, the inhibitory eﬀects of genis-
tein, kaempferol, and daidzein on STAT-1 activation have
not been reported previously, whereas quercetin was found
to inhibit IFNγ-induced activation of STAT-1 in mouse
BV-2 microglia [29]. The mechanisms by which genistein,
kaempferol, quercetin, and daidzein inhibit STAT-1 activa-
tion are not known, but may be associated with inhibi-
tion of phosphorylation of STAT-1 or its up-stream kinase
JAK2 [36]. Interestingly, the three most potent inhibitors
of iNOS expression and NO production, that is, genistein,
kaempferol, and quercetin, inhibited both NF-κBa n dS T A T -
1 activations, whereas those ﬂavonoids inhibiting only NF-
κBh a das m a l l e re ﬀect on iNOS expression. Because NF-κB
and STAT-1 are involved in the activation of several inﬂam-
matory genes, ﬂavonoids that inhibit activation of NF-κB
and/or STAT-1 are likely to down-regulate production of an
arrayofinﬂammatorymediatorsinadditiontoiNOS.There-
fore the present results oﬀer an additional molecular mecha-
nism for the anti-inﬂammatory action of ﬂavonoids.
In conclusion, we compared the eﬀects of 36 naturally
occurring ﬂavonoids and related polyphenolic compounds
on LPS-induced NO production and iNOS expression in ac-
tivated macrophages. The ﬂavonoid classes containing the
most eﬀective compounds were isoﬂavones and ﬂavonols.
We identiﬁed eight compounds as being able to inhibit LPS-
induced NO production and iNOS expression. Four com-
pounds (genistein, kaempferol, quercetin, and daidzein) in-
hibited activation of both of the important transcription fac-
tors for iNOS, that is, STAT-1 and NF-κB, whereas four com-
pounds (ﬂavone, isorhamnetin, naringenin, and pelargoni-
din) inhibited only NF-κB. The results partly explain the
anti-inﬂammatory eﬀects of ﬂavonoids.
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